Novomet-Trio 2 Tablet SR
Novomet-Trio 2 Tablet SR
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Ozomet-VG2 Tablet SR
Ozone Pharmaceuticals Ltd
Voglibose 0.2mg
Pack Size
1 units
Price
Save ₹73
that's 62% off!
About This Medicine
Product description & overview
Novomet-Trio 2 Tablet SR is a triple-combination antidiabetic medication, featuring Glimepiride (2mg), Metformin (500mg), and Voglibose (0.2mg). This pharmaceutical formulation is designed to improve glycemic control in type 2 diabetes mellitus patients. Glimepiride, a sulfonylurea, stimulates insulin secretion, while Metformin, a biguanide, reduces hepatic glucose production and improves insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, delays carbohydrate absorption in the gut. This synergistic action aims to achieve optimal blood glucose management and ensure patient safety and efficacy. Always consult a healthcare professional for proper dosage and administration guidelines.
Active composition
Glimepiride 2 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Novomet-Trio 2 Tablet SR.
High Risk
Pregnancy
Novomet-Trio 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Novomet-Trio 2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Novomet-Trio 2 Tablet SR may be needed. Please consult your doctor. Novomet-Trio 2 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Novomet-Trio 2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Novomet-Trio 2 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Novomet-Trio 2 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Novomet-Trio 2 Tablet SR
